News
16h
Money Talks News on MSNYour Wegovy Access Just Changed: What Patients Need to Know NowNovo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...
The much hyped weightloss drug Wegovy, also marketed as Ozempic, is expected to be in high demand when it becomes available in New Zealand from tomorrow. But the drug is unfunded so users hoping to ...
The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, official data revealed more than 100 deaths in the United Kingdom had now ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.
16h
inews.co.uk on MSNGet your NHS weight-loss jab at the pharmacy under Streeting obesity planThe Health Secretary will set out a 10-year plan including proposals to bring down the cost of drugs such as Wegovy and ...
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...
UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...
The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...
Patients have been referred to hospital emergency departments after mistakenly overdosing on diabetes drugs such as Ozempic, The Daily Telegraph can reveal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results